StartupHistory

An open directory of startups through time

Public records · dated sources
Free to read. Free to reuse.

Company records / diacarta.com

DiaCarta, Inc.

DiaCarta, Inc. (diacarta.com): 8 changes recorded in its website history since June 2010. Homepage last checked 6 November 2026.

Recorded changes

Newest observations first. Each interval bounds when the website changed; it is not an exact event date.

  1. ComplianceBetween and

    Now states ISO 13485 compliance on its homepage.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  2. HeadlineBetween and
    BeforePress Release
    AfterBreaking News!

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  3. HeadlineBetween and
    BeforeAccurately Detects Orf1ab, N and E Genes with High Throughput
    AfterPress Release

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  4. HeadlineBetween and
    BeforeCANCER GENE MUTATION DETECTION
    AfterAccurately Detects Orf1ab, N and E Genes with High Throughput

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  5. ComplianceBetween and

    Now states FDA-APPROVED compliance on its homepage.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  6. HiringBetween and

    Added a careers page.

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  7. HeadlineBetween and
    BeforeDedicated to the Science of Impact
    AfterCANCER GENE MUTATION DETECTION

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation
  8. HeadlineBetween and
    BeforeDiaCarta technologies deliver faster, more sensitive results for diagnostic and molecular genetic testing.
    AfterDedicated to the Science of Impact

    Observed on the company’s website; business claims are not independently verified.

    earlier archived pagelater archived pageLink to observation

First recorded website

Observed 26 June 2010

Our earliest capture with readable facts. This is our first observation, not when the company introduced these things. These website claims are not independently verified.

How it described itself

DiaCarta Index

archived pageLink to first observation

All facts above belong to this capture. Unlisted fields mean we have no readable observation, not that they were absent.

How it describes itself

Similar headlines are grouped together. The quote shown is from the last capture in each group, not necessarily the exact wording throughout that period.

  1. July 2024 – November 2026 · 3 captures · latest observed messagingBreaking News!

    This wording observed 6 November 2026.

    current websiteHistorical capture not publicly available
    Inspect 3 captures in this group
  2. Seen July 2022 · 1 capturePress Release

    This wording observed 4 July 2022.

    archived page
  3. Seen January 2021 · 1 captureAccurately Detects Orf1ab, N and E Genes with High Throughput

    DiaCarta Redefines Precision Molecular Diagnostics through Cancer Gene Mutation Detection Test.

    This wording observed 16 January 2021.

    archived page
  4. Seen July 2019 · 1 captureCANCER GENE MUTATION DETECTION

    DiaCarta Redefines Precision Molecular Diagnostics through Cancer Gene Mutation Detection Test.

    This wording observed 20 July 2019.

    archived page
  5. Seen October 2017 · 1 captureDedicated to the Science of Impact

    Improving patient care through novel precision molecular diagnostics: CE/IVD marked tests are available for detection of KRAS, NRAS, EGFR, BRAF, PIK3CA, JAK2. HPV QuantiVirus® cervical and head-neck c

    This wording observed 15 October 2017.

    archived page
  6. Seen January 2016 · 1 captureDiaCarta technologies deliver faster, more sensitive results for diagnostic and molecular genetic testing.

    Improving patient care through novel precision molecular diagnostics: CE/IVD marked tests are available for detection of KRAS, NRAS, EGFR, BRAF, PIK3CA, JAK2. HPV QuantiVirus® cervical and head-neck c

    This wording observed 24 January 2016.

    archived page
  7. Seen September 2014 · 1 captureDiaCartaDiaCarta provides precise gene mutation test kits

    Improving patient care through novel precision molecular diagnostics: CE/IVD marked tests are available for detection of KRAS, NRAS, EGFR, BRAF, PIK3CA, JAK2 and customizing. HPV QuantiVirus® cervical

    This wording observed 28 September 2014.

    archived page
  8. June 2010 – June 2012 · 2 capturesDiaCarta Index

    DiaCarta LLC is a leading Company focusing on molecular diagnostics with novel reagents and device.DiaCarta provides a large portfolio of proven and reliable solutions to meet your testing needs for i

    This wording observed 6 June 2012.

    archived page
    Inspect 2 captures in this group

Cite this record

StartupHistory, “DiaCarta, Inc.” company record, https://startuphistory.org/c/diacarta.com

Machine-readable: /c/diacarta.com.json. How changes are found: method.